In the previous tumor investigations, a number of studies were carried out to estimate the association between the polymorphisms (+49 G/A, −1661 A/G, −1722 T/C, −318 C/T and CT60 G/A) of CD152 gene and the susceptibility to BC. This evidence concerns the gene CTLA4 and breast cancer.